Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicoletta Finotti"'
Publikováno v:
Pharmacological Research. 42:287-291
Oxidative stress and mitochondrial damage are involved in Parkinson's disease (PD). Several drugs used for PD treatment have demonstrated antioxidant properties. To evaluate the antioxidant efficacy of cabergoline, an ergot derivative with a long pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62400c883f08d5e0602994a3283badaf
https://doi.org/10.1006/phrs.2000.0690
https://doi.org/10.1006/phrs.2000.0690
Autor:
Pil Woo Huh, Isabel Saul, Nicoletta Finotti, Myron D. Ginsberg, Ludmila Belayev, Weizhao Zhao, Raul Busto
Publikováno v:
Brain Research. 845:107-111
The purpose of this study was to determine whether treatment with high-dose human serum albumin (HSA) would offer protection in a model of high-grade transient forebrain ischemia. Twenty-six fasted Wistar rats underwent bilateral common carotid arter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55004e23e9c7d9f5f6223061bd1a8797
https://doi.org/10.1016/s0006-8993(99)01952-6
https://doi.org/10.1016/s0006-8993(99)01952-6
Autor:
Michela Ceriani, Nicoletta Finotti, Rita Levi-Montalcini, Enzo Martegani, Laura Lenzi, Lilia Alberghina, Anna Maria Colangelo, Luigi Aloe
Recombinant human nerve growth factor (rhNGF) is regarded as the most promising therapy for neurodegeneration of the central and peripheral nervous systems as well as for several other pathological conditions involving the immune system. However, rhN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2216a606ba82b893de49e9a9f6195ea8
http://hdl.handle.net/10281/13011
http://hdl.handle.net/10281/13011
Autor:
Nicoletta Finotti, Elena Borasio, Orietta Pansarasa, Laura Bertorelli, Fulvio Marzatico, Mauro Moroni, Camillo Porta, Laura Castagna
Publikováno v:
Cancer chemotherapy and pharmacology. 45(2)
Purpose: Amifostine (WR-2721), a phosphorylated aminothiol pro-drug which is an analogue of cysteamine, is a selective cytoprotective agent for normal tissues from the toxicities associated with chemotherapy and irradiation. Despite a growing number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ff69e4d275e6e5196ca5f4d3876c7a
https://pubmed.ncbi.nlm.nih.gov/10663633
https://pubmed.ncbi.nlm.nih.gov/10663633
Autor:
Fulvio Marzatico, Nicoletta Finotti, Elena Borasio, R Greco, M RegazziBonora, Camillo Porta, Laura Bertorelli, Mauro Moroni
Publikováno v:
Europe PubMed Central
Amifostine (WR-2721, Ethyol(TM)) is a chemo-and radioprotective agent which is increasingly used in clinical practice to minimize antitumor therapy-induced toxicities. The key of this property of amifostine is certainly its selective action in terms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e9d816f11c75aab6115657bc32e23a
http://europepmc.org/abstract/med/21590129
http://europepmc.org/abstract/med/21590129